<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02084420</url>
  </required_header>
  <id_info>
    <org_study_id>IY-81149-HB03</org_study_id>
    <nct_id>NCT02084420</nct_id>
  </id_info>
  <brief_title>Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment</brief_title>
  <official_title>PhaseⅢ Study of A Multicenter, Randomized, Double-blind, Active-controlled to Evaluate of Efficacy /Safety as H. Pylori Eradication Effect Between Ilaprazole/Pantoprazole</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Il-Yang Pharm. Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Il-Yang Pharm. Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate of efficacy and safety as H.pylori eradiation effect&#xD;
      between Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric and/or&#xD;
      Duodenal ulcer patients with H.pylori positive infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to evaluate of efficacy and safety as H.pylori eradiation effect between&#xD;
      Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric and/or Duodenal&#xD;
      ulcer patients with H.pylori positive infection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the rate of H.pylori eradication</measure>
    <time_frame>participants will be followed at 7 weeks (visit 4)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the rate of Gastric and/or Duodenal ulcer curation</measure>
    <time_frame>participants will be followed at 7 weeks (visit 4)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">323</enrollment>
  <condition>Peptic Ulcer</condition>
  <arm_group>
    <arm_group_label>Ilaprazole or Pantoprazole placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ilaprazole 10mg, Pantoprazole 40mg, Amoxicillin 1000mg, Clarithromycin 500mg 2 times/day, PO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ilaprazole placebo or Pantoprazole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pantoprazole 40mg, Ilaprazole 10mg, Amoxicillin 1000mg, Clarithromycin 500mg 2 times/day,PO</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ilaprazole</intervention_name>
    <description>10mg 2 BID( 2 times / day), before breakfast and dinner</description>
    <arm_group_label>Ilaprazole or Pantoprazole placebo</arm_group_label>
    <other_name>NOLTEC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pantoprazole</intervention_name>
    <description>40mg, BID(2 times / day), before breakfast and dinner</description>
    <arm_group_label>Ilaprazole placebo or Pantoprazole</arm_group_label>
    <other_name>PANTOLOC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 year old ≤ Male or female &lt; 75 year old&#xD;
&#xD;
          -  Patients who had endoscopically confirmed Gastric and/or duodenal ulcer and H.pylori&#xD;
             infection confirmed by Urea Breath Test&#xD;
&#xD;
          -  Patients who understand the study conditions&#xD;
&#xD;
          -  Patients who had been given the explanation about the study, and had provided&#xD;
             voluntary written informed consent to participate in the stud&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with known allergy or hypersensitivity reaction to the Investigational&#xD;
             products&#xD;
&#xD;
          -  Patients who use the Investigational products&#xD;
&#xD;
          -  Patients who undergone H.pylori eradication&#xD;
&#xD;
          -  Patients with abnormal laboratory results, as specified below:&#xD;
&#xD;
        Total bilirubin, creatinine &gt; 1.5 x upper limit of normal Aspartate transminase, Alanine&#xD;
        transminase, Alkaline phosphatase, Blood urea nitrogen &gt; 2 x upper limit of normal&#xD;
&#xD;
          -  Patients who used Proton Pump Inhibitor agents or antibiotics within the last 2 weeks&#xD;
             before the start of the Investigational products&#xD;
&#xD;
          -  Pregnant women and lactating women&#xD;
&#xD;
          -  Women of childbearing potential who were not using a medically acceptable method of&#xD;
             contraception during the study period.(Menopausal women who did not have a menstrual&#xD;
             period for at least 12 months were considered infertile)&#xD;
&#xD;
          -  Patients with uncontrolled Diabetes mellitus&#xD;
&#xD;
          -  Patients with uncontrolled Hypertension&#xD;
&#xD;
          -  Patients with Alcoholics&#xD;
&#xD;
          -  Patients with a history of malignancy within 5 years prior to the study entry (Day 1)&#xD;
             (except for basal cell carcinoma of the skin)&#xD;
&#xD;
          -  Patients who had undergone a esophageal or gastric surgery&#xD;
&#xD;
          -  Patients who had a hereditary disorder as galactose intolerance, lactose intolerance,&#xD;
             glucose-galactose malabsorption&#xD;
&#xD;
          -  Patients who had participated in other investigational study within 30 days before the&#xD;
             study entry (Day 1)&#xD;
&#xD;
          -  Patients who, in the investigator's opinion, are not suitable for the study for any&#xD;
             other reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>IL YANG PHARM</last_name>
    <role>Study Director</role>
    <affiliation>IL-YANG Pharmaceutical Co.LTD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Soonchunhang University Hospital</name>
      <address>
        <city>Bucheon-si, Gyeonggi-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyungpook National University Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Konyang University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gachon University Gill Medical Center</name>
      <address>
        <city>Incheon city</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonkwang University of Medicine &amp; Hospital</name>
      <address>
        <city>Jeollabuk-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung Ang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ewha Womens University Mokdong Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University Seoul Paik Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KyungHee University Medical center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul Asan hoapital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Seoul</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital</name>
      <address>
        <city>Wonju-si, Gangwon-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <study_first_submitted>March 5, 2014</study_first_submitted>
  <study_first_submitted_qc>March 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2014</study_first_posted>
  <last_update_submitted>June 2, 2014</last_update_submitted>
  <last_update_submitted_qc>June 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peptic Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pantoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

